Literature DB >> 17676591

Immunocontraceptive effect of Izumo and enhancement by combination vaccination.

Rajesh K Naz1.   

Abstract

Sperm proteins are being investigated for their applications in the development of contraceptive vaccines (CV) in several laboratories. In the present study, various synthetic peptides based upon four sperm proteins, namely Izumo, fertilization antigen-1 (FA-1), YLP(12), and SP56 that are involved in various steps of the fertilization cascade were examined for their immunocontraceptive effect. The synthetic peptides were conjugated to four carrier proteins namely keyhole limpet hemocyanin (KLH), bovine serum albumin (BSA), chicken gamma-globulin, and chicken ovalbumin. Female mice were immunized with various peptide vaccines and each booster injection was given with the peptide conjugated to a different carrier protein. Two different fertility trials with different doses of the peptide vaccines were conducted to examine the contraceptive effect. Injection of 150 microg of the peptides (Trial II) caused a significantly higher immune response in serum as well as in the vaginal tract causing enhanced contraceptive effect than those observed after injection with 75 microg of the peptides (Trial I). Immunization with the peptide vaccines based upon Izumo, which is involved in sperm-egg plasma membrane fusion, caused a significant reduction in fertility. The contraceptive effect was enhanced by immunizing with the peptides based upon other antigens (FA-1, YLP(12), and SP56), resulting in an overall 73.33% reduction in fertility. When the antibodies against the peptides disappeared after >9-10 months from circulation and genital tract, all the animals regained fertility. These findings indicate for the first time that the immunization with Izumo and other sperm peptides namely FA-1, YLP(12), and SP56 induces antibodies in serum and genital tract that cause a reversible long-term contraceptive effect in female mice. The data further indicate that the proteins involved in sperm-egg fusion can also be used for contraceptive vaccine development. The contraceptive effects are enhanced by immunizing with the multipeptide vaccines. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17676591     DOI: 10.1002/mrd.20783

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  14 in total

1.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

Review 2.  Antisperm contraceptive vaccines: where we are and where we are going?

Authors:  Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2011-04-11       Impact factor: 3.886

3.  LM23 is a novel member of the Speedy/Ringo family at the crossroads of life and death of spermatogenic cell.

Authors:  Yi-Ming Cheng; Mei-Ling Liu; Meng-Chun Jia
Journal:  Asian J Androl       Date:  2011-05       Impact factor: 3.285

Review 4.  Status of contraceptive vaccines.

Authors:  Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2009-01       Impact factor: 3.886

Review 5.  Development of genetically engineered human sperm immunocontraceptives.

Authors:  Rajesh K Naz
Journal:  J Reprod Immunol       Date:  2009-10-23       Impact factor: 4.054

Review 6.  Vaccine for human contraception targeting sperm Izumo protein and YLP12 dodecamer peptide.

Authors:  Rajesh K Naz
Journal:  Protein Sci       Date:  2014-04-22       Impact factor: 6.725

Review 7.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 8.  Vaccines for immunological control of fertility.

Authors:  Satish K Gupta; Pankaj Bansal
Journal:  Reprod Med Biol       Date:  2009-12-01

9.  Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception.

Authors:  Bhawana Shrestha; Alison Schaefer; Yong Zhu; Jamal Saada; Timothy M Jacobs; Elizabeth C Chavez; Stuart S Olmsted; Carlos A Cruz-Teran; Gabriela Baldeon Vaca; Kathleen Vincent; Thomas R Moench; Samuel K Lai
Journal:  Sci Transl Med       Date:  2021-08-11       Impact factor: 17.956

10.  Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen.

Authors:  Jianwei Zhou; Cui Kong; Zhaohong Yuan; Junmin Luo; Rui Ma; Jiang Yu; Jinghe Cao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.